Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease [Phase 1]
A Phase 1 trial evaluated cardiac outcomes of the Rotigotine Transdermal System in adults with advanced-stage Parkinson's disease, and resul…
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor [Phase 3]
Two Phase 3 studies are evaluating ALTROPANE for SPECT imaging of upper-extremity tremor in Parkinsonian syndromes; the current status of th…
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's Disease [NA]
This clinical trial update summarizes results from a completed study evaluating deep brain stimulation for Parkinson's disease. It examines …
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms [Phase 2]
Phase 2 study evaluating efficacy, safety, and tolerability of rotigotine nasal spray for acute treatment of Parkinson's symptoms has comple…
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD) [Phase 4]
This document reports the completion and posted results of a Phase 4 clinical trial evaluating pramipexole (Mirapex) for early treatment of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease [Phase 3]
An open-label extension in Phase 3 evaluated the long-term safety of rotigotine in early-stage Parkinson's disease. The trial is completed a…
-
CLINICAL_TRIALS trial_result · 2010-01-18Clinical Trial Update: Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors [Phase 4]
Phase 4 pharmacokinetic study evaluating levodopa/carbidopa infusion with and without oral COMT inhibitors in Parkinson disease, and the stu…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients [Phase 4]
A Phase 4 randomized, double-blind trial comparing pramipexole at two dosing regimens to placebo in early Parkinson disease completed with r…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease [Phase 3]
This open-label extension trial assesses the long-term safety of rotigotine in patients with advanced Parkinson's disease in a Phase 3 study…
-
CLINICAL_TRIALS trial_result · 2009-12-25Clinical Trial Update: White Matter Pathology in Parkinson's Disease (PD)
This clinical trial update reports on white matter pathology in Parkinson's disease, sponsored by Tel-Aviv Sourasky Medical Center, and list…
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) [Phase 2]
Phase 2 trial evaluating ropinirole extended-release tablets as monotherapy for Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS research · 2009-12-23Clinical Trial Update: The Effect of Electrode Implantation for Deep Brain Stimulation (DBS) on Brain Function Using Single Photon Emission Computed Tomography (SPECT) With Technetium-99m-ethyl Cysteinatedimer (Tc-ECD) [NA]
This clinical trial update investigates how deep brain stimulation electrode implantation affects brain function in Parkinson's disease, ass…
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease [Phase 3]
An open-label Phase 3 extension trial assessed the long-term safety of rotigotine in advanced Parkinson's disease. The study has completed a…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: Select Stim: Selective Stimulation of the Subthalamic Nucleus in Parkinson's Disease. "A Feasibility Study" [NA]
This document reports a feasibility study evaluating selective stimulation of the subthalamic nucleus for Parkinson disease. The study has c…
-
CLINICAL_TRIALS trial_result · 2009-12-11Clinical Trial Update: Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP) [Phase 4]
This clinical trial update notes that the Phase 4 TAP/DAP study evaluating treatment of agitation and psychosis in dementia/parkinsonism has…
-
FDA approval · 2009-12-09FDA Approved: AZILECT — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for AZILECT (rasagiline mesylate) submitted by Teva Neuroscience.
-
FDA approval · 2009-12-07FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for amantadine hydrochloride from PAI Holdings dba PAI Pharma.
-
CLINICAL_TRIALS research · 2009-11-25Clinical Trial Update: Apathy in Parkinson Disease: Clinical, Physiopathological and Pharmacological Study
This clinical trial investigates apathy in Parkinson's disease across clinical, pathophysiological, and pharmacological dimensions. The curr…
-
CLINICAL_TRIALS trial_result · 2009-11-20Clinical Trial Update: Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease [Phase 3]
Phase 3 trial evaluating overnight switch from immediate-release to extended-release pramipexole in early Parkinson's disease; results compl…
-
CLINICAL_TRIALS trial_result · 2009-11-20Clinical Trial Update: First Presentation of Parkinson Disease Patients to Neurologist
A Boehringer Ingelheim-led trial update describes Parkinson disease patients presenting to neurologists, with results posted in 2009.
-
CLINICAL_TRIALS research · 2009-11-19Clinical Trial Update: The Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease [NA]
This clinical trial update investigates whether low-frequency repetitive transcranial magnetic stimulation (r-TMS) affects motor and cogniti…
-
CLINICAL_TRIALS research · 2009-11-10Clinical Trial Update: Spectroscopy in Parkinson Disease
An update on a spectroscopy-based clinical trial for Parkinson disease with no current status listed.
-
CLINICAL_TRIALS trial_result · 2009-11-09Clinical Trial Update: Retinal Function in Parkinson's Disease
This clinical trial update reports on retinal function research in Parkinson's disease. The current trial status is unknown.
-
FDA approval · 2009-10-30FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for a generic carbidopa/levodopa product from Dr. Reddy's Laboratories.
-
FDA approval · 2009-10-30FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Carbidopa and Levodopa from Dr. Reddy's Laboratories Inc, authorizing the generic product.